AI in healthcare: statistics and facts 2025
Artificial intelligence in healthcare has crossed from experimental to essential. In 2025, the technology is not being piloted in research labs, it is reading radiology scans in hospitals, transcribing physician notes in real time, identifying drug candidates in pharmaceutical labs, and flagging high-risk patients before they deteriorate.
The global AI in healthcare market grew from $1.1 billion in 2016 to approximately $36.67 billion in 2025, a 3,234% increase in nine years. No major industry sector has adopted AI this rapidly. The AI investment context driving healthcare technology is in our AI worldwide statistics analysis.
Three numbers define the current state of AI in healthcare. First: 66% of physicians now use AI, up from 38% in 2023, a 78% increase in just two years. Second: the FDA has approved 1,247 AI-powered medical devices, 956 of which are used in radiology. Third: AI delivers an average ROI of $3.20 for every $1 invested.
These are not projections, they are confirmed 2025 data points. The financial markets context for healthcare technology investment is in our U.S. financial markets analysis.
AI in Healthcare Market Size — $36.7B in 2025 to $110.6B by 2030 (CAGR 38.6%)
The AI in healthcare market is one of the fastest-growing segments in both AI and healthcare technology. From $1.1 billion in 2016 to an estimated $22.4 billion in 2023, and then accelerating to approximately $36.67 billion in 2025. MarketsandMarkets projects the market will reach $110.61 billion by 2030 at a CAGR of 38.6%.
Grand View Research projects $505.59 billion by 2033 at 38.9% CAGR. Precedence Research estimates $613.81 billion by 2034. The variation between firms reflects different scope definitions, the growth trajectory is consistent across all sources.
- 2016: $1.1B — Pre-deep learning mainstream. Early adopters in radiology and genomics only. AI in healthcare was largely theoretical.
- 2020: ~$6.7B — COVID-19 accelerated adoption. 94% of healthcare executives expanded AI during the pandemic. Telehealth + AI diagnostic tools went from pilot to production in months.
- 2023: $22.4B — Generative AI enters healthcare. ChatGPT inspired clinical documentation tools, virtual assistants, and AI scribes. Market grew 1,779% from 2016.
- 2025: $36.67B — 1,247 FDA-approved AI devices. 66% physician adoption. 85% of healthcare organizations using or exploring GenAI. Software leads at 46% of revenue.
- 2030E: $110.61B — MarketsandMarkets projection. Agentic AI in clinical workflows, AI-designed drugs entering trials, and AI-powered surgical systems driving growth.
FDA-Approved AI Medical Devices — 1,247 Total, 956 in Radiology (May 2025)
The most concrete measure of AI's integration into clinical practice is the number of AI-powered medical devices approved by the U.S. Food and Drug Administration. By the end of May 2025, the FDA had approved 1,247 AI and machine learning medical devices.
The overwhelming majority, 956 devices (76.7%), are used in radiology, reflecting the exceptional fit between deep learning and medical image analysis. AI radiology tools can screen X-rays, CT scans, MRIs, and mammograms at scale, flagging abnormalities for specialist review and enabling earlier diagnosis.
- Radiology — 956 devices (76.7%): By far the largest category. AI radiology tools analyse X-rays, CT scans, MRI images, and mammograms. Leading applications: lung cancer screening, bone fracture detection, stroke identification, and diabetic retinopathy screening. AI can match or exceed radiologist accuracy on specific tasks while processing images in seconds.
- Cardiovascular — 116 devices (9.3%): AI ECG analysis, cardiac imaging, arrhythmia detection. DeepRhythmAI achieved a 0.3% false-negative rate vs 4.4% for human technicians in a study of 14,606 patients. AI can rule out heart attacks twice as fast as humans with 99.6% accuracy.
- Neurology — 56 devices (4.5%): AI stroke diagnosis, brain tumour detection, Alzheimer's risk assessment. By the close of 2023, every stroke centre in the UK had AI stroke diagnosis technology available.
- Anesthesiology — 22 devices: AI-powered dosage management, patient monitoring during surgery, risk stratification for anaesthetic complications.
- Hematology — 19 devices: AI blood analysis, cell counting, leukaemia and lymphoma screening from blood smears and bone marrow samples.
AI Adoption in Healthcare — 66% of Physicians Use AI, 85% of Organizations Exploring GenAI
Physician AI adoption has crossed the majority threshold in 2025 for the first time. 66% of physicians used health AI in 2025, up from 38% in 2023, a 78% increase in two years. Among those using AI, 68% reported recognising advantages in patient care (up from 63% in 2023).
AI-generated operative reports demonstrated 87.3% accuracy versus surgeon-written reports at 72.8%, a 14.5% improvement. Meanwhile, physician burnout remains a serious concern: 54% of physicians experienced burnout in 2025 (down from 60%) and 57% reported low well-being. AI-powered documentation tools are the primary technology being deployed to address this.
The investment banking context for healthcare AI is in our investment banking analysis.
At the organisational level, 85% of healthcare organisations had adopted or explored generative AI by end of 2024, up from 72% in Q1 2024. What began as cautious experimentation has become mainstream practice: AI for clinical documentation, patient communication, diagnostic support, and supply chain management.
However, less than 10% of healthcare organisations have been using AI for more than five years, meaning the majority of deployments are recent and still maturing. The dominant barriers remain cost, immature tools, and regulatory uncertainty. By 2025, 90% of hospitals are expected to utilise AI-powered technology for early diagnosis and remote patient monitoring.
The broader healthcare investment context is in our BlackRock investment analysis.
AI Healthcare Applications — Diagnostics, Surgery, Drug Discovery, Documentation and More
AI is being applied across virtually every dimension of healthcare, from the highly clinical to the purely administrative. Robot-assisted surgery is the largest single application segment by revenue share (13%+), followed by medical imaging and diagnostics (22.3%), and administrative workflow automation. Diagnosis and early detection is expected to register the highest CAGR of 39.8% through 2030 (MarketsandMarkets).
Drug discovery and development has the second-highest CAGR at 21.2%. The software component leads the market at 44.3–46% of revenue, reflecting the dominance of AI software platforms over hardware. Cloud-based deployment accounts for 71.64% of the market and is growing at 41.7% CAGR.
The global corporate investment context for AI applications is in our world's most valuable companies analysis.
AI Diagnostic Accuracy — Heart Attacks 99.6%, Surgical Reports 87.3%, Cancer Detection Specialist-Level
The clinical evidence for AI's diagnostic accuracy has strengthened dramatically in 2025, with peer-reviewed studies confirming AI performance at or above specialist level in key applications. A meta-analysis across diagnostic tasks found machine learning algorithms performing at 87% sensitivity and 92% accuracy.
In a 2025 study of 158 surgical cases, AI operative reports showed a 14.5% improvement in accuracy over surgeon-written reports (87.3% vs 72.8%). In cardiac monitoring, DeepRhythmAI achieved a 0.3% false-negative rate, versus 4.4% for human technicians. AI can rule out heart attacks twice as fast as humans with 99.6% accuracy.
These results are not from controlled lab environments, they are from real clinical deployments.
The data consistently shows AI outperforming human specialists on specific, bounded diagnostic tasks, particularly those involving pattern recognition in large datasets. AI reads a chest X-ray in seconds with the same accuracy as a specialist who spent years training. AI processes 14,606 ECG recordings and misses only 0.3% of abnormalities, while trained human technicians miss 4.4%. The key nuance: AI excels at the pattern-recognition component of diagnosis but lacks the broader clinical judgment, patient communication, and contextual understanding that physicians bring. The clinical consensus is that AI works best as a second reader or decision support tool, augmenting physician capability rather than replacing it. This is also why 68% of physicians in 2025 reported recognising AI's advantages while simultaneously raising concerns about over-reliance and tool immaturity.
AI in Drug Discovery — 66% of Life Sciences Executives Investing, 10-40% Faster Drug Approvals
Drug discovery is one of the most capital-intensive and time-consuming processes in all of industry. Bringing a new drug from initial discovery to market approval takes 10-15 years and costs $2-3 billion on average. AI is attacking this problem from multiple angles simultaneously.
In 2025, 66% of life sciences executives report investing in generative AI specifically for drug discovery, analysing chemical interactions, identifying new protein structures (building on AlphaFold2's breakthrough), and generating novel molecular candidates. AI is estimated to enable 10-40% faster drug approval rates. The AI in drug discovery market reached $1.86 billion in 2024 (CAGR 29.9%).
The pharmaceutical industry's adoption of AI accelerated sharply in 2025. In January 2025, NVIDIA partnered with IQVIA, Illumina, Mayo Clinic, and Arc Institute specifically to enhance drug discovery through agentic and generative AI. In January 2026, OpenAI acquired healthcare startup Torch to integrate its "unified medical memory" technology, aggregating lab results, medications, and visit recordings, into ChatGPT Health.
AI-designed drug candidates have entered clinical trials, and AI is reducing molecular screening time from years to weeks. The economic impact: AI could generate $100 billion to $600 billion in total healthcare savings by 2050. The broader financial investment context is in our global investment banking analysis.
Healthcare AI Investment — $6.4B in H1 2025, Abridge $550M, Truveta $320M
Venture capital continues to flood into healthcare AI at record pace. In the first half of 2025, digital health venture funding reached $6.4 billion, slightly above the $6 billion raised in H1 2024.
AI-enabled healthcare startups captured 62% of all digital health venture dollars ($3.95 billion), raised rounds 83% larger on average than non-AI peers, and secured 9 of the 11 mega-deals exceeding $100 million. The average deal size rose to $26.1 million as later-stage rounds gained strength. The AI finance and investment context is in our AI in finance analysis.
- Abridge $550M: Clinical documentation AI. Automatically transcribes and summarises physician-patient conversations into structured medical notes. Directly addresses physician burnout from documentation burden. Raised $250M in February 2025 and $300M in June 2025 — two mega-rounds in four months.
- Truveta $320M: Health data platform. Aggregates real-world clinical data from 30+ US health systems (40+ million patients) to power AI drug discovery, clinical trials, and outcomes research. Uses data that was previously siloed and inaccessible.
- Innovaccer $275M: AI health platform for unified patient data management and population health analytics. Serves hospitals, health systems, and payers with AI-powered care coordination tools.
- Hippocratic AI $141M: AI nursing assistants designed to handle routine patient communication — appointment reminders, pre-visit instructions, medication adherence follow-ups. Targets the $20B annual cost of nursing administrative tasks.
AI Healthcare by Region — North America Leads at 54%, Asia Pacific Grows Fastest
North America dominates global AI in healthcare, accounting for approximately 42.6–54% of global AI healthcare revenue in 2024-2025. The US AI healthcare market alone was estimated at $18.1 billion in 2025, projected to reach $222.9 billion by 2033 (CAGR 36.9%, Grand View Research).
The US advantage reflects its advanced digital health infrastructure, widespread EHR adoption, large patient data repositories, and the concentration of major AI companies (Microsoft, Google, NVIDIA, IBM) investing heavily in healthcare AI. Asia Pacific is the fastest-growing region, driven by ageing populations, government AI healthcare initiatives, and rapid digital infrastructure investment.
In EU healthcare, patient monitoring is the most prevalent projected AI function, expected in 72% of EU healthcare facilities. The global GDP and healthcare spending context is in our world GDP analysis.
AI in Healthcare — Key Statistics and Facts 2025
AI in Healthcare Forecast — $110.6B by 2030, $505B by 2033
The AI in healthcare market is on course to become one of the largest technology verticals in the world. MarketsandMarkets projects the market will reach $110.61 billion by 2030 at a CAGR of 38.6% from 2025. Grand View Research projects a larger figure of $505.59 billion by 2033 at 38.9% CAGR, using a broader market definition that includes hardware and AI-enabled services. Precedence Research estimates $613.81 billion by 2034. The US AI healthcare market alone is projected at $222.9 billion by 2033. The broader AI investment context driving these forecasts is in our AI worldwide statistics analysis.
By 2050, AI is projected to generate between $100 billion and $600 billion in total healthcare cost savings globally, primarily through faster drug approvals, reduced hospital care spending, and productivity gains across clinical workflows. By 2028, Gartner projects that 33% of enterprise software will include agentic AI, and healthcare is expected to be among the highest-adoption industries. 90% of hospitals are expected to use AI-powered technology for early diagnosis and remote patient monitoring by 2025. The global economic impact of AI across all sectors is in our world GDP analysis.
Frequently Asked Questions — AI in Healthcare 2025
The global AI in healthcare market is valued at approximately $21.66–$36.96 billion in 2025. MarketsandMarkets: $21.66B. Grand View Research: $36.67B. All sources agree on a CAGR of approximately 38–39%, projecting the market to $110.61 billion by 2030. Source: MarketsandMarkets, Grand View Research, Precedence Research 2025.
By May 2025, the FDA had approved 1,247 AI and ML-powered medical devices. Of these, 956 are used in radiology (76.7%), 116 in cardiovascular care, 56 in neurology, 22 in anesthesiology, and 19 in hematology. Source: FDA AI/ML Device Database, Vention Teams 2025.
66% of physicians used health AI in 2025, up from 38% in 2023, a 78% increase in two years. 68% reported recognising advantages in patient care. AI-generated reports showed 87.3% accuracy vs 72.8% for surgeon-written reports. Source: DemandSage, December 2025.
The average ROI on AI in healthcare is $3.20 for every $1 invested, with typical returns within 14 months. AI nursing assistants save $20B/year. AI-assisted surgeries could save $40B/year (20% shorter stays). Projected total savings by 2050: $100B–$600B. Source: DemandSage, DialogHealth 2025.
AI demonstrates strong diagnostic accuracy: 99.6% accuracy ruling out heart attacks, twice as fast as humans. DeepRhythmAI: 0.3% false-negative rate vs 4.4% for human technicians. ML algorithms: 87% sensitivity, 92% accuracy (meta-analysis). AI surgical reports: 87.3% vs 72.8% surgeon-written. Source: Nature Medicine, DemandSage 2025.
Main applications by market share: Robot-assisted surgery (13%+, largest), Medical imaging and diagnostics (22.3%), Drug discovery (highest CAGR 21.2%), Clinical documentation (fastest consumer adoption), Remote patient monitoring, Administrative automation. Diagnosis and early detection expected at 39.8% CAGR. Source: MarketsandMarkets, Precedence Research 2025.
North America leads at 42.6–54% of global AI healthcare revenue. US market: $18.1B in 2025, projected to $222.9B by 2033. Asia Pacific is the fastest growing, driven by ageing populations and government AI health initiatives. EU patient monitoring AI: expected in 72% of facilities. Source: Grand View Research, MarketsandMarkets 2025.
85% of healthcare organizations explored or adopted GenAI by end 2024 (up from 72% in Q1 2024). Key uses: clinical documentation (Abridge $550M), drug discovery (66% of life sciences executives investing), patient communication, synthetic data. OpenAI acquired Torch in January 2026 to integrate medical memory into ChatGPT Health. Source: Vention Teams 2025.
In H1 2025, digital health VC reached $6.4 billion. AI startups captured 62% ($3.95B) and secured 9 of 11 mega-deals over $100M. Top deals: Abridge $550M, Truveta $320M, Innovaccer $275M, Hippocratic AI $141M. Average deal size: $26.1M (+83% vs non-AI peers). Source: Vention Teams, Rock Health 2025.
66% of life sciences executives invest in GenAI for drug discovery. AI estimates: 10–40% faster drug approval rates. Drug discovery AI market: $1.86B in 2024 (CAGR 29.9%). NVIDIA partnered with Mayo Clinic, Illumina, and Arc Institute in January 2025 for AI drug discovery. AI reduces molecular screening from years to weeks. Source: Vention Teams, Market.us 2025.
Key barriers: immature tools, high implementation costs, regulatory uncertainty, shortage of skilled AI professionals in healthcare, lack of standardized frameworks, data privacy (HIPAA/GDPR), poor EHR interoperability, and physician reluctance. Less than 10% of healthcare organizations have used AI for more than 5 years, meaning most deployments are still maturing. Source: DemandSage, MarketsandMarkets 2025.
The US AI in healthcare market was $18.1 billion in 2025 (Grand View Research), projected to reach $222.9 billion by 2033 at a CAGR of 36.9%. The US generated the highest AI healthcare revenue globally in 2023 at $11.8 billion, nine times greater than the UK ($1.33B). US annual healthcare spending is expected to reach $6.8 trillion by 2030. Source: Grand View Research 2025.
In 2025, 54% of physicians experienced burnout (down from 60%), while 57% reported low well-being. AI clinical documentation tools (Abridge, Nuance DAX) automatically transcribe physician-patient conversations, directly reducing the documentation burden that is a primary burnout driver. AI can automate up to 20% of nurses' administrative tasks ($20B annual savings). EHR AI reduced documentation time 40% in pilot studies. Source: Vention Teams, DemandSage 2025.
Grand View Research, AI in Healthcare Market Size Report 2025
MarketsandMarkets, AI in Healthcare Market Forecast 2025-2030
Vention Teams, AI in Healthcare Statistics 2025
DemandSage, AI in Healthcare Statistics and Facts, December 2025